Studies have shown that Drp1 expression is upregulated in a variety of cancers and that Drp1 is associated with several metabolic pathways leading to cancer, including the PI3K-Akt, MAPK/ERK1/2, mTOR, AMPK, and Wnt/β-cyclin pathways (28). This evidence concerns the gene MAPK3 and cancer.